| Literature DB >> 29049350 |
Syed Babar Jamal1, Syed Shah Hassan1,2, Sandeep Tiwari1, Marcus V Viana1, Leandro de Jesus Benevides1, Asad Ullah2, Adrián G Turjanski3, Debmalya Barh4, Preetam Ghosh5, Daniela Arruda Costa1, Artur Silva6, Richard Röttger7, Jan Baumbach7, Vasco A C Azevedo1,8.
Abstract
Corynebacterium diphtheriae (Cd) is a Gram-positive human pathogen responsible for diphtheria infection and once regarded for high mortalities worldwide. The fatality gradually decreased with improved living standards and further alleviated when many immunization programs were introduced. However, numerous drug-resistant strains emerged recently that consequently decreased the efficacy of current therapeutics and vaccines, thereby obliging the scientific community to start investigating new therapeutic targets in pathogenic microorganisms. In this study, our contributions include the prediction of modelome of 13 C. diphtheriae strains, using the MHOLline workflow. A set of 463 conserved proteins were identified by combining the results of pangenomics based core-genome and core-modelome analyses. Further, using subtractive proteomics and modelomics approaches for target identification, a set of 23 proteins was selected as essential for the bacteria. Considering human as a host, eight of these proteins (glpX, nusB, rpsH, hisE, smpB, bioB, DIP1084, and DIP0983) were considered as essential and non-host homologs, and have been subjected to virtual screening using four different compound libraries (extracted from the ZINC database, plant-derived natural compounds and Di-terpenoid Iso-steviol derivatives). The proposed ligand molecules showed favorable interactions, lowered energy values and high complementarity with the predicted targets. Our proposed approach expedites the selection of C. diphtheriae putative proteins for broad-spectrum development of novel drugs and vaccines, owing to the fact that some of these targets have already been identified and validated in other organisms.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29049350 PMCID: PMC5648181 DOI: 10.1371/journal.pone.0186401
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Strains of C. diphtheriae employed in the pan-modelome study with information on genomes statistics, disease prevalence and location of isolation.
| Strain | GPID | NCBI Accession | Genome Size (Mb) | Proteins | GC% | Location | Biovar |
|---|---|---|---|---|---|---|---|
| 31A | PRJNA42399 | NC_016799.1 | 2.53535 | 2258 | 53.60 | Brazil | — |
| 241 | PRJNA42407 | NC_016782.1 | 2.42655 | 2245 | 53.40 | Brazil | — |
| BH8 | PRJNA42423 | NC_016800.1 | 2.48552 | 2223 | 53.60 | Brazil | — |
| C7 | PRJNA42401 | NC_016801.1 | 2.49919 | 2230 | 53.50 | USA | — |
| CDCE8392 | PRJNA42405 | NC_016785.1 | 2.43333 | 2135 | 53.60 | USA | Mitis |
| HC01 | PRJNA42409 | NC_016786.1 | 2.42715 | 2162 | 53.40 | Brazil | Mitis |
| HC02 | PRJNA42411 | NC_016802.1 | 2.46861 | 2179 | 53.70 | Brazil | Mitis |
| HC03 | PRJNA42415 | NC_016787.1 | 2.47836 | 2186 | 53.50 | Brazil | Mitis |
| HC04 | PRJNA42417 | NC_016788.1 | 2.48433 | 2190 | 53.50 | Brazil | Gravis |
| INCA402 | PRJNA42419 | NC_016783.1 | 2.44907 | 2163 | 53.70 | Brazil | Belfanti |
| PW8 | PRJNA42403 | NC_016789.1 | 2.53068 | 2200 | 53.70 | USA | — |
| VA01 | PRJNA42421 | NC_016790.1 | 2.39544 | 2100 | 53.40 | Brazil | Gravis |
| NCTC13129 | PRJNA87 | NC_002935.2 | 2.48863 | 2185 | 53.50 | UK | Gravis |
Drug and/or vaccine target prioritization parameters and functional annotation of the eight essential non-host homologous putative targets.
| Gene and protein codes | Official full name | Cavities with DS | Cavities with DS | Mol. Wt | Functions | Cellular component | Pathways | Virulence |
|---|---|---|---|---|---|---|---|---|
| NP_939692.1, | Transcription antitermination protein NusB/ N utilization substance protein B homolog | 0 | 2 | 20.382 | unknown | No | ||
| NP_939612.1, | Phosphoribosyl-ATP pyrophosphatase | 0 | 1 | 9.877 | Cytoplasm | Biosynthesis of amino acids | Yes | |
| NP_939445.1, | Iron ABC transporter membrane protein/ Putative iron transport membrane protein, FecCD-family | 2 | 3 | 35.470 | Membrane | The ATP-binding cassette (ABC) transporters form one of the largest known protein families | Yes | |
| NP_939345.1, | Hypothetical protein DIP0983/ Uncharacterized protein | 0 | 4 | 28.193 | Cytoplasm | unknown | Yes | |
| NP_939302.1, | Fructose 1,6-bisphosphatase II | 3 | 2 | 35.589 | Carbohydrate Metabolism | No | ||
| NP_939123.1, | SsrA-binding protein | 1 | 2 | 18.784 | Cytoplasm | unknown | Yes | |
| NP_938900.1, | 30S ribosomal protein S8 | 1 | 1 | 14.292 | Extracellula/ | unknown | No | |
| NP_938502.1, | Biotin synthase | 3 | 1 | 38.224 | Cytoplasm | Biotin metabolism | Yes |
aDruggability predicted with DoGSiteScorer software. A druggability score above 0.60 is considered to be good, but a score above 0.80 is favored [32].
bMolecular weight was determined using ProtParam tool (http://web.expasy.org/protparam/).
cMolecular function (MF) and biological process (BP) for each target protein was determined using UniProt.
dCellular localization of pathogen targets was performed using CELLO.
eKEGG was used to find the role of these targets in different cellular pathways.
fPAIDB was used to check if the putative targets are involved in the pathogen’s virulence.
gDS = Drug Score
Drug and/or vaccine target prioritization parameters and functional annotation of the fifteen essential host homologous putative targets.
| Gene and protein codes | Official full name | Cavities with DS | Cavities with DS | Mol. Wt | Functions | Cellular | Pathways | Virulence |
|---|---|---|---|---|---|---|---|---|
| NP_938651.1 | Recombination protein RecR | 0 | 2 | Cytoplasm | Homologous recombination | |||
| NP_938792.1 | Putative electron transport related protein | 2 | Cytoplasm/ | |||||
| NP_938922.1 | 30S ribosomal protein S13 | 1 | Cytoplasm | Ribosome | ||||
| NP_939046.1 | Putative uptake hydrogenase small subunit | 0 | Cytoplasm | Microbial metabolism in diverse environments | ||||
| NP_939341.1 | Tetrahydropicolinate succinylase | 1 | Cytoplasm | Biosynthesis of amino acids | ||||
| NP_939343.1 | Putative succinyltransferase | 1 | Cytoplasm | Biosynthesis of amino acids | ||||
| NP_939460.1 | Acetolactate synthase small subunit | 3 | Cytoplasm/ | 2-Oxocarboxylic acid metabolism | ||||
| NP_939590.1 | Precorrin-4 C11-methyltransferase | 2 | Cytoplasm | Porphyrin and chlorophyll metabolism | ||||
| NP_939786.1 | Putative transport membrane protein | 3 | Membrane | The ATP-binding cassette (ABC) transporters | ||||
| NP_939832.1 | Putative uroporphyrinogen III methyltransferase | 2 | Cytoplasm | Porphyrin and chlorophyll metabolism | ||||
| NP_939958.1 | Phospho-2-dehydro-3-deoxyheptonate aldolase | 3 | Cytoplasm | Biosynthesis of amino acids | ||||
| NP_940018.1 | Putative GTP cyclohydrolase 1 type 2 | 1 | Cytoplasm | — | ||||
| NP_940228.1 | Serine acetyltransferase | 0 | Cytoplasm | Carbon metabolism | ||||
| NP_940284.1 | Putative pyruvate dehydrogenase | 1 | Cytoplasm | (PYRUVATE METABOLISM) Nicotinate and nicotinamide metabolism | ||||
| NP_940605.1 | Putative DNA protection during starvation protein | 1 | Cytoplasm | — |
aDruggability predicted with DoGSiteScorer software. A druggability score above 0.60 is usually considered, but a score above 0.80 is favored [32].
b Molecular weight was determined using ProtParam tool (http://web.expasy.org/protparam/).
c Molecular function (MF) and biological process (BP) for each target protein was determined using UniProt.
dCellular localization of pathogen targets was performed using CELLO.
eKEGG was used to find the role of these targets in different cellular pathways.
fPAIDB was used to check if the putative targets are involved in the pathogen’s virulence.
gDS = Drug Score.
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected best-ranked molecules against NP_939302.1 (glpX, Fructose 1,6-bisphosphatase II).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -64.1265 | 3/ Val95, Asp197 | |
| Jacarandic Acid | -62.0658 | 4/ Asp96, Thr98, Asp197, Pro221 | |
| 16-hydrazonisosteviol | -64.2107 | 5/ Asp93, Val95, Asp96, Val198 | |
| 16-oxime, 17-hydroxyisosteviol | -69.6824 | 4/ Asp93, Asp96, Thr98 | |
| Benzyl ester isosteviol lactone | -69.8464 | 3/ Asp93, Asp197, Glu222 | |
| ZINC00042420 | -106.97 | 3/ Arg175, Arg197, Val198 | |
| ZINC13142972 | -109.648 | 3/ Asp93, Asp197, Glu222 | |
| ZINC67912153 | -135.111 | 13/Gly64, Glu65, Asp93, Val95, Gly97, Thr98, Phe127, Arg175, Glu222 | |
| ZINC67902753 | -121.762 | 8/Glu65, Val95, Thr98, Glu222 | |
| ZINC38143633 | -123.150 | 11/Lys37, Asp93, Val95, Asp96, Gly97, Thr98 | |
*NP = Natural Product (http://zinc.docking.org/catalogs/acdiscnp)
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939692.1 (nusB, Transcription antitermination protein NusB).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -78.0652 | 1/ Asp36 | |
| Jacarandic Acid | -68.1913 | 3/ Asp36, Glu91, Arg98 | |
| 16-hydrazonisosteviol | -92.7911 | 2/ Glu31, Leu73 | |
| ZINC00053531 | -99.4716 | 3/ Asp34, Asp36, Ala69 | |
| ZINC19899354 | -114.966 | 3/ Asp36, Ala69, Asp77 | |
| ZINC67911826 | -131.288 | 7/Ala30, Glu31, Asp34, Ile35, Arg102 | |
| ZINC15043210 | -124.580 | 7/ Glu31, Ile35, Leu73 Glu91, Arg102 | |
| ZINC31168395 | -131.442 | 6/ Glu31, Asp34, Ala69, Leu73, Asp77, Arg102 | |
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_938900.1 (rpsH, 30S ribosomal protein S8).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -48.8803 | 3/ Asp5, Arg15 | |
| Jacarandic Acid | -49.3506 | 4/ Ser12, Val77 | |
| 16-hydrazonisosteviol | -68.2446 | 3/ Asp5, Arg13, Arg79 | |
| 17-hydroxyisosteviol | -64.5855 | 5/ Asp5, Arg79 | |
| 16–17 dihydroxyisosteviol | -56.3868 | 4/ Asp5, Arg79 | |
| 16-oxime, 17-hydroxyisosteviol | -65.1995 | 4/ Ser26, Ser29, Ser30 | |
| ZINC15221730 | -103.636 | 5/ Ala8, Arg15, Arg79 | |
| ZINC71913776 | -87.1474 | 5/ Arg15, Arg79 | |
| ZINC72333100 | -104.807 | 3/ Arg15, Arg79, Val80 | |
| ZINC35457686 | -107.091 | 10/Ala8, Ser12, Arg15, Val77, Arg78, Arg79, Lys82 | |
| ZINC67903079 | -131.210 | 10/ Asp5, Ser12, Arg15, Arg78, Arg79, Lys82 | |
| ZINC31163223 | -100.684 | 7/ Ala8, Asp9, Arg78, Arg79, Lys82 | |
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_938502.1 (bioB, Biotin synthase).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -72.2918 | 3/ Tyr183, Asn184, His185 | |
| Jacarandic Acid | -98.0169 | 2/ Ala132, Glu188 | |
| 16-hydrazonisosteviol | -107.55 | 4/ Gly165, Tyr183, Asn184, Glu188 | |
| 17-hydroxyisosteviol | -92.2141 | 4/ Cys93, Ala132, Val134, Tyr183 | |
| 16-oxime, 17-hydroxyisosteviol | -98.9592 | 5/ Glu95, Val134, Glu188, Arg206, Thr323 | |
| Benzyl ester isosteviol lactone | -89.8881 | 5/ Ala132, Val134, Gly165, Asn184 | |
| ZINC16952914 | -119.354 | 5/ Val134, Ile164, Gly165, Asn184, Asn186 | |
| ZINC77269615 | -164.853 | 17/Cys86, Phe92, Cys93, Ser94, Gln95, Ala132, Val134, Ser163, Asn184, Asn186, Arg206 | |
| ZINC04098512 | -162.050 | 14/ Cys86, Cys90, Cys93, Ala132, Val134, Asn184, Asn186, His201, Arg206, Asp256, Thr323 | |
| ZINC15112225 | -142.080 | 10/ Phe92, Cys93, Ser94, Gln95, Asn186, Arg206, Asn253 | |
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939612.1 (hisE, Phosphoribosyl-ATP pyrophosphatase).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -54.9556 | 1/ Tyr84 | |
| Jacarandic Acid | -61.0241 | 3/ Leu87 | |
| 16–17 dihydroxyisosteviol | -70.8496 | 3/ Leu65, Tyr84 | |
| ZINC05809437 | -89.6781 | 1/ Asp5 | |
| ZINC38143703 | -99.499 | 4/ Thr79, Ile83, Leu87 | |
| ZINC67913372 | -97.997 | 5/ Gly36, Ile62, Ile83, Tyr84 | |
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939123.1 (smpB, SsrA-binding protein).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -67.698 | 3/ Ser16, Ser114, Leu115 | |
| Jacarandic Acid | -52.3689 | 1/ Asn69 | |
| 16-hydroxyisosteviol | -53.2141 | 4/ Ser50, Thr52, Asn69 | |
| 16-hydrazonisosteviol | -64.6203 | 3/ Thr52, Asn67 | |
| 16–17 dihydroxyisosteviol | -59.7364 | 3/ Ser16, Lys19, Val49 | |
| ZINC01414475 | -86.7944 | 3/ Thr52, Asn67, Asn69 | |
| ZINC17128469 | -74.5349 | 3/ Ser16, Leu51, Thr52 | |
| ZINC31168211 | -158.056 | 12/ Asn9, Ser16, Val49, Ser50, Thr52, Asp53, Ser54, Thr109 | |
| ZINC33832449 | -134.974 | 10/ Asn9, Ser16, Asn17, Val49, Ser50, Thr52, Asp53 | |
| ZINC04096316 | -137.613 | 9/ Asn9, Ser10, Ser16, Asn17, Lys19, Val49, Ser50, Thr52 | |
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939445.1 (DIP1084, Putative iron transport membrane protein, FecCD-family).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -66.4406 | 1/ Ser164 | |
| Jacarandic Acid | -77.5981 | 1/ Gly265 | |
| 16-hydrazonisosteviol | -96.3945 | 4/ Tyr97, Ser164, Ile266 | |
| 17-hydroxyisosteviol | -90.1488 | 4/ Tyr97, Ser164, Ile266 | |
| Benzyl ester isosteviol lactone | -71.4733 | 4/ Tyr97, Ser164 | |
| ZINC01645563 | -95.7116 | 5/ Tyr97, Ser102, Ser164, Ile266 | |
| ZINC13142972 | -111.185 | 5/ Ser103, Ser106, Thr110, Ser164, Ser168 | |
| ZINC62023045 | -103.542 | 4/ Tyr97, Ser102, Ser106, Ser164 | |
| ZINC70454922 | -155.667 | 10/ Tyr97, Ser102, Ser106, Ser168, Ser172, Met191, Gly319 | |
| ZINC31167925 | -135.535 | 10/ Tyr97, Ser164, Ser168, Met191, Gly265, Ile266, Thr322 | |
| ZINC04963990 | -127.671 | 8/ Asp95, Tyr97, Ser106, Met191, Ile266, Phe268 | |
Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939345.1 (DIP0983, hypothetical protein DIP0983).
| Compounds | MolDock Score | H-Bond/Residues | |
|---|---|---|---|
| Rhein | -55.7819 | 3/ Cys13, Leu17, Asp177 | |
| Jacarandic Acid | -80.8294 | 3/ Cys13, Gly14 | |
| 17-hydroxyisosteviol | -95.9025 | 2/ His11, Cys13 | |
| 16–17 dihydroxyisosteviol | -83.7226 | 2/ His11, Cys13 | |
| ZINC00114311 | -125.423 | 6/ Arg10, Arg155, Gly172 | |
| ZINC00211173 | -98.6064 | 7/ Arg10, Gly106, Arg155, Gly174, Asp177 | |
| ZINC01427915 | -112.22 | 6/ Arg10, Ala77, Arg78, Gly172, Gly174 | |
| ZINC04836994 | -136.847 | 5/ Arg10, Gly106, Ile131, Glu132 | |
| ZINC32004947 | -146.72 | 5/ Arg10, Gly106, Ile131, Glu132 | |
| ZINC67911471 | -176.091 | 13/ Asn8, Cys13, Ser76, Ala77, Arg78 Arg150, Arg155, Gly174, Thr175 | |
| ZINC31163223 | -162.908 | 12/ Asn8, Arg10, His11, Arg150, Arg155, Gly172, Thr175 | |
| ZINC04096393 | -148.423 | 10/ Glu9, Arg10, Ala77, Arg78, Arg155, Lys156, Thr175 | |